We also found that RFA increased the infiltration of CD8+PD-1+ T cells in distant non-RFA tumor on day 3 after RFA treatment, whereas at the same time upregulated the expression of PD-1 and LAG3, the critical immune checkpoint regulators in the T cells. The gene discussed is LAG3; the disease is neoplasm.